Abstract
Rationale
Conflicting results have been reported regarding the role of the nitric oxide (NO)–cyclic guanosine monophosphate (cGMP) pathway in the hippocampus on anxiety modulation.
Objectives
To investigate the effects of intrahippocampal injections of drugs that modify the NO–cGMP pathway in rats submitted to two animal models that are sensitive to anxiolytic drugs, the elevated plus-maze and the Vogel punished licking test.
Materials and methods
Male Wistar rats with cannulae aimed at the dentate gyrus of the dorsal hippocampus received microinjections of the NO synthase (NOS) inhibitors N G-nitro-L-arginine methyl ester (LNAME, 15–300 nmol/0.2 μl), N G-nitro-L-arginine (LNOARG, 50–300 nmol/0.2 μl), 7-nitroindazole (7NI, 10–100 nmol/0.2 μl), or the soluble guanylate cyclase inhibitor 1H-oxadiazolo-quinoxalin-1 one (ODQ, 10–100 nmol/0.2 μl), and were submitted to the elevated plus-maze. In a second group, the animals received 7NI, LNAME, or ODQ and were submitted to the Vogel punished licking test. To control for drug-induced changes in locomotor behavior, the animals were submitted to an open arena or to the Rota-rod test.
Results
All drugs increased the exploration of the open arms of the elevated plus-maze. They also increased the number of punished licks in the Vogel test, indicating an anxiolytic effect. The anxiolytic effect of LNAME was prevented by previous treatment with L-arginine (300 nmol/0.2 μl). Except for the lower dose of LNAME (15 nmol), administration of the NOS inhibitors or ODQ did not change exploratory activity in the open field nor cause any gross locomotor impairment in the Rota-rod test.
Conclusion
The results suggest that NO plays an anxiogenic role in the dentate gyrus of the dorsal hippocampus.
Similar content being viewed by others
Abbreviations
- NMDA:
-
N-methyl-D-aspartate
- NADPH:
-
nicotinamide adenine dinucleotide phosphate
- NOS:
-
nitric oxide synthase
- sGC:
-
soluble guanylate cyclase enzyme
- dlPAG:
-
dorsolateral periaqueductal gray matter
- 7NI:
-
7-nitroindazole
- cGMP:
-
cyclic guanosine monophosphate
- LNOARG:
-
NG-nitro-l-arginine
- LNAME:
-
NG-nitro-L-arginine methyl ester hydrochloride
- ODQ:
-
1H-oxadiazolo-quinoxalin-1 one
- DMSO:
-
dimethyl sulfoxide
- ANOVA:
-
one-way analysis of variance
- CA:
-
Ammon’s horn
- 5-HT:
-
5-hidroxy-tryptamine
References
Alderton WK, Cooper CE, Knowles RG (2001) Nitric oxide synthases: structure, function and inhibition. Biochem J 357:593–615
Araki T, Mizutani H, Matsubara M, Imai Y, Mizugaki M, Itoyama Y (2001) Nitric oxide synthase inhibitors cause motor deficits in mice. Eur Neuropsychopharmacol 11:125–133
Bannerman DM, Rawlins JNP, McHugh SB, Deacon RMJ, Yee BK, Bast T, Zhang WN, Pothuizen HHJ, Feldon J (2004) Regional dissociations within the hippocampus-memory and anxiety. Neurosci Biobehav Rev 28:273–283
Barjavel MJ, Bhargava HN (1995) Nitric oxide synthase activity in regions and spinal cord of mice and rats: kinetic analysis. Pharmacology 50:168–174
Bertoglio LJ, Joca SRL, Guimarães FS (2006) Further evidence that anxiety and memory are regionally dissociated within the hippocampus. Behav Brain Res 175:183–188
Bredt DS, Glatt CE, Hwang PM, Fotuhi M, Dawson TM, Snyder SH (1991) Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase. Neuron 7:615–624
Carobrez AP, Bertoglio LJ (2005) Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Neurosci Biobehav Rev 29:1193–1205
Contestabile A (2000) Roles of NMDA receptor activity and nitric oxide production in brain development. Brain Res Rev 32:476–509
Cruz PM, Frei F, Graeff FG (1994) Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol Biochem Behav 49:171–176
de Oliveira CL, Del Bel EA, Guimarães FS (1997) Effect of LNOARG on plus-maze performance in rats. Pharmacol Biochem Behav 56:55–59
Del Bel EA, Souza AS, Guimarães FS, da-Silva CA, Nucci-da-Silva LP (2002) Motor effects of acute and chronic inhibition of nitric oxide synthesis in mice. Psychopharmacology 161:32–37
Del Bel EA, Guimarães FS, Echeverry MB, Gomes MZ, Souza AS, Padovan Neto FE, Tumas V, Barion Cavalcanti A, Lazzarini M, Nucci da Silva L, Paula Souza D (2005) Role of nitric oxide on motor behavior. Cell Mol Neurobiol 25:371–392
de-Oliveira RW, Guimarães FS (1999) Anxiolytic effect of methylene blue microinjected into the dorsal periaqueductal gray matter. Braz J Med Biol Res 32:1529–1532
Dunn RW, Reed TA, Copeland PD, Frye CA (1998) The nitric oxide synthase inhibitor 7-nitroindazole displays enhanced anxiolytic efficacy without tolerance in rats following subchronic administration. Neuropharmacology 37:899–904
Echeverry MB, Guimarães FS, Del Bel EA (2004) Acute and delayed restraint stress-induced changes in nitric oxide producing neurons in limbic regions. Neuroscience 125:981–993
Esplugues JV (2002) NO as a signaling molecule in the nervous system. Br J Pharmacol 135:1079–1095
Ferreira VM, Valenzuela CF, Morato GS (1999) Role of nitric oxide-dependent pathways in ethanol-induced anxiolytic effects in rats. Alcohol Clin Exp Res 23:1898–1904
Forestiero D, Manfrim CM, Guimarães FS, de Oliveira RMW (2006) Anxiolytic-like effects induced by nitric oxide synthase inhibitors microinjected into the medial amygdala of rats. Psychopharmacology 184:166–172
Garthwaite J (1991) Glutamate, nitric oxide and cell–cell signaling in the nervous system. Trends Neurosci 14:60–67
Gray JA, McNaughton N (2000) The neuropsychology of anxiety, 2nd edn. Oxford University Press, Oxford
Griffith OW, Stuehr DJ (1995) Nitric oxide synthases: properties and catalytic mechanism. Annu Rev Physiol 57:707–736
Guerra GP, Mello CF, Sauzen PD, Berlese DB, Furian AF, Tabarelli Z, Rubin MA (2006) Nitric oxide is involved in the memory facilitation induced by spermidine in rats. Psychopharmacology 186:150–158
Guimarães FS, de Aguiar JC, Del Bel EA, Ballejo G (1994) Anxiolytic effect of nitric oxide inhibitors microinjected into the dorsal central grey. NeuroReport 5:1929–1932
Guimarães FS, Beijamini V, Moreira FA, Aguiar DC, Lucca AC (2005) Role of nitric oxide in brain regions related to defensive reactions. Neurosci Biobehav Rev 29:1313–1322
Hecker M, Mitchell JA, Harris HJ, Katsura M, Thiemermann C, Vane JR (1990) Endothelial cells metabolize NG-monomethyl-L-arginine to L-citrulline and subsequently to L-arginine. Biochem Biophys Res Commun 167:1037–1043
Jardim MC, Guimarães FS (2004) Role of glutamate ionotropic receptors in the dorsomedial hypothalamus nucleus on anxiety and locomotor behavior. Pharmacol Biochem Behav 79:541–546
Joca SR, Guimarães FS (2006) Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects. Psychopharmacology 185:298–305
Joca SR, Padovan CM, Guimarães FS (2003) Activation of post-synaptic5-HT1A receptors in the dorsal hippocampus prevents learned helplessness development. Brain Res 978:177–184
Kriegsfeld LJ, Eliasson MJ, Demas GE, Blackshaw S, Dawson TM, Nelson RJ, Snyder SH (1999) Nocturnal motor coordination deficits in neuronal nitric oxide synthase knock-out mice. Neuroscience 89:311–315
Li S, Quock RM (2001) Comparison of N2O- and chlordiazepoxide-induced behaviors in the light/dark exploration test. Pharmacol Biochem Behav 68:789–796
Li S, Quock RM (2002) Effects of a nitric oxide donor on behavior and interaction with nitrous oxide in the mouse light/dark exploration test. Eur J Pharmacol 447:75–78
Lovick TA (2000) Panic disorder—a malfunction of multiple control systems within the midbrain periaqueductal gray matter? Neuroscientist 6:48–58
Menard J, Treit D (2001) The anxiolytic effects of intra-hippocampal midazolam are antagonized by intra-septal 1-glutamate. Brain Res 888:163–166
Miki N, Kawabe Y, Kuriyama K (1977) Activation of cerebral guanylate cyclase by nitric oxide. Biochem Biophys Res Commun 75:851–856
Millan MJ (2003) The neurobiology and control of anxious states. Prog Neurobiol 70:83–244
Millan MJ (2006) Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application. Pharmacol Ther 110:135–370
Moncada S, Higgs A (1993) The l-arginine nitric oxide pathway. N Engl J Med 329:2002–2012
Mongeau R, Blier P, de Montigny C (1997) The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments. Brain Res Rev 23:145–195
Monzon ME, Varas MM, De Barioglio SR (2001) Anxiogenesis induced by nitric oxide synthase inhibition and anxiolytic effect of melanin-concentrating hormone (MCH) in rat brain. Peptides 22:1043–1047
Moreira FA, Molchanov ML, Guimarães FS (2004) Ionotropic glutamate-receptor antagonists inhibit the aversive effects of nitric oxide donor injected into the dorsolateral periaqueductal gray of rats. Psychopharmacology 171:199–203
Padovan CM, Guimarães FS (2004) Antidepressant-like effects of NMDA-receptor antagonist injected into the dorsal hippocampus of rats. Pharmacol Biochem Behav 77:15–19
Paxinos G, Watson C (1997) The rat brain in stereotaxic coordinates, 3rd edn. Academic, San Diego
Pellow S, Chopin P, File SE, Briley YM (1985) Validation of open-closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149–167
Podhorna J, Brown RE (1999) Inhibition of nitric oxide synthase reduces ultrasonic vocalizations of rat pups. Eur J Pharmacol 382:143–150
Quock RM, Nguyen E (1992) Possible involvement of nitric oxide in chlordiazepoxide-induced anxiolysis in mice. Life Sci 51:PL255–PL260
Roohbakhsh A, Moghaddam AH, Massoudi R, Zarrindast MR (2007) Role of dorsal hippocampal cannabinoid receptors and nitric oxide in anxiety like behaviours in rats using the elevated plus-maze test. Clin Exp Pharmacol Physiol 34:223–229
Sisitaga A, Miras-Portugal MT, Sánchez-Pietro J (1997) Modulation of glutamate release by a nitric oxide/cyclic GMP-dependent pathway. Eur J Pharmacol 321:247–257
Susswein AJ, Katzoff A, Miller N, Hurwitz I (2004) Nitric oxide and memory. Neuroscientist 10:153–166
Tan SE (2007) Roles of hippocampal nitric oxide and calcium/calmodulin-dependent protein kinase II in inhibitory avoidance learning in rats. Behav Pharmacol 18:29–38
Tatarczynska E, Klodzinska A, Kroczka B, Chojnacka-Wojcik E, Pilc A (2001) The antianxiety-like effects of antagonists of group I and agonists of group II and III metabotropic glutamate receptors after intrahippocampal administration. Psychopharmacology 158:94–99
Trabace L, Kendrick KM (2000) Nitric oxide can differentially modulate striatal neurotransmitter concentrations via soluble guanylate cyclase and peroxynitrite formation. J Neurochem 75:1664–1764
Treit D, Menard J, Royan C (1993) Anxiogenic stimuli in the elevated plus-maze. Pharmacol Biochem Behav 44:463–469
Vale AL, Green S, Montgomery AM, Shafi S (1998) The nitric oxide synthesis inhibitor L-NAME produces anxiogenic-like effects in the rat elevated plus-maze test, but not in the social interaction test. J Psychopharmacol 12:268–272
Valtschanoff JG, Weinberg RJ, Kharasia VN, Nakane M, Schmidt HH (1993) Neurons in rat hippocampus that synthesize nitric oxide. J Comp Neurol 331:111–121
Vincent SR, Kimura H (1992) Histochemical Mapping of nitric oxide synthase in the rat brain. Neuroscience 46:755–784
Vogel JR, Beer B, Clody DE (1971) A simple and reliable conflict procedure for testing anti-anxiety agents. Psychopharmacologia 21:1–7
Volke V, Koks S, Vasar E, Bourin M, Bradwejn J, Mannisto PT (1995) Inhibition of nitric oxide synthase causes anxiolytic-like behavior in an elevated plus-maze. NeuroReport 6:1285–1288
Volke V, Koks S, Vasar E, Bourin M, Bradwejn J, Mannisto PT (1997) 7-Nitroindazole, a nitric oxide synthase causes anxiolytic properties in exploratory models of anxiety. Psychopharmacology 131:399–405
Yildiz F, Ulak G, Erden BF, Gacar N (2000) Anxiolytic-like effects of 7-nitroindazole in the rat plus-maze test. Pharmacol Biochem Behav 65:199–202
Acknowledgements
The authors acknowledge the helpful technical support provided by C.A. Silva and R. Ferreira. The study was supported by grants from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and the Fundação de Amparo à Pesquisa do Estado de São Paulo (Fapesp).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Spolidório, P.C.M., Echeverry, M.B., Iyomasa, M. et al. Anxiolytic effects induced by inhibition of the nitric oxide–cGMP pathway in the rat dorsal hippocampus. Psychopharmacology 195, 183–192 (2007). https://doi.org/10.1007/s00213-007-0890-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-007-0890-0